SU1 COST-EFFECTIVENESS OF CYCLOOXYGENASE-2 INHIBITOR PARECOXIB COMPARED TO OPIOIDS AFTER NONCARDIAC SURGERY INTHE UNITED KINGDOM

Autor: Remák, E, Muszbek, N, Manson, SC, Zlateva, G, Chen, C
Zdroj: In Value in Health 2007 10(6):A230-A230
Databáze: ScienceDirect